Food and Drugs Administration

Arthritis Advisory Committee

June 24, 2003

Slides

Disclaimer

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Etanercept (Enbrel®) for the Treatment of Ankylosing Spondylitis, Amgen (HTM) (PPT)

Etanercept (Enbrel®) for the Treatment of Ankylosing Spondylitis - Backup Visuals, Amgen (HTM) (PPT)

Etanercept Immunex BLA 103795/5123, Dr. William Tauber, MD, et. al., FDA (HTM) (PPT)